Background: Rectal tenesmus is a distressing symptom in patients with advanced cancer and challenging to treat. There is lack of consensus on the appropriate management of tenesmus in this patient population.
Aim: To identify and examine the effectiveness of interventions to palliate rectal tenesmus caused by advanced cancer when surgery, radiotherapy or chemotherapy are no longer treatment options.
Design: A systematic review of the literature following standard systematic review methodology and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidance.
Data Sources: A comprehensive search of the electronic databases MEDLINE, EMBASE and the Cochrane Library was conducted from date of inception to April 2016. PubMed 'related articles' search, grey literature search and hand-searches of the bibliographies of relevant papers and textbooks were also performed. Non-cancer patients were excluded. Any studies involving surgery or radiotherapy to treat tenesmus were excluded. Studies involving interventions to treat pelvic pain syndromes without specific outcome measures on severity of tenesmus were excluded. The quality of the studies was assessed using a National Institute for Health and Clinical Excellence-recommended quality assessment tool.
Results: From 861 studies, 9 met full criteria and were selected. All were case series investigating the use of pharmacological interventions (diltiazem, nifedipine, methadone, mexiletine hydrochloride, lidocaine and bupivacaine), anaesthetic interventions (lumbar sympathectomy, neurolytic superior hypogastric plexus block), and endoscopic laser interventions. The included studies showed substantial heterogeneity, and therefore, a meta-analysis was not feasible.
Conclusion: From this review, we identified a significant gap in research into the palliation of rectal tenesmus. A multimodal approach may be necessary due to the complexity of the pathophysiology of tenesmus. Future research should focus on randomised controlled trials of drug therapies whose potential effectiveness is suggested by case series.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0269216317697897 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Separating Infectious Proctitis from Inflammatory Bowel Disease-A Common Clinical Conundrum.
Microorganisms
November 2024
Department of Gastroenterology, St George's University Hospital, London SW17 0QT, UK.
Proctitis refers to inflammation in the rectum and may result in rectal bleeding, discharge, urgency, tenesmus, and lower abdominal pain. It is a common presentation, particularly in genitourinary medicine and gastroenterology, as the two most common causes are sexually transmitted infections and inflammatory bowel disease. The incidence of infective proctitis is rising, particularly amongst high-risk groups, including men who have sex with men, those with HIV seropositive status, and those participating in high-risk sexual behaviours.
View Article and Find Full Text PDFAPAVAC Immunotherapy for the Adjuvant Treatment of a Canine Mucosal Melanoma.
Vet Sci
December 2024
Ospedale Veterinario I Portoni Rossi, Anicura Italy Holding, via Roma 51, 40069 Zola Predosa, Italy.
An 11-year-old spayed female Beagle presented with tenesmus and was identified with a rectal wall mass. Diagnostic imaging (abdominal ultrasound and computed tomography) localised the mass in the right rectal wall and documented no evidence of metastatic disease. Subsequently, the dog underwent surgery for tumour excision.
View Article and Find Full Text PDFAssessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system.
Front Pharmacol
November 2024
The Second Clinical College of Dalian Medical University, Dalian Medical University, Dalian, Liaoning, China.
Article Synopsis
- Plecanatide is a gastro-peptide used to treat chronic constipation and IBS with constipation, and this study aimed to evaluate its long-term safety in real-world scenarios.
- Data from the FDA Adverse Event Reporting System between 2017 and 2024 revealed 861 cases and 2057 adverse event reports, with diarrhea and abdominal issues being common side effects.
- The study suggests that most adverse events occur within the first week of treatment and provides critical safety insights for healthcare providers prescribing plecanatide.
Endoscopic features of rectal mucosal prolapse syndrome (RMPS): Differentiation from malignant rectal tumor.
Endosc Int Open
November 2024
Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Article Synopsis
- - Rectal mucosal prolapse syndrome (RMPS) often presents with symptoms like rectal bleeding and can be mistaken for malignant rectal tumors (MRT) during endoscopic exams; this study aimed to differentiate between the two and examine RMPS characteristics.
- - A total of 826 patients were analyzed, revealing that RMPS patients were younger, had smaller lesions, and a longer clinical course compared to those with MRT.
- - Five distinct morphological phenotypes of RMPS lesions were identified, with gender differences noted in lesion types; key features like age, lesion size, and clinical duration can help differentiate RMPS from MRT.
Intradural extramedullary cystic lesions: an interesting cauda equina cysticercosis case report and a literature review.
BMC Neurol
November 2024
Department of Spine, Affiliated Hospital of Jining Medical University, Jining, China.
Background: Intraspinal cysticercosis, usually with serious neurological deterioration, is rarely diagnosed because its clinical manifestations are nonspecific, and most physicians might not be familiar with its imaging features.
Case Presentation: A 50-year-old woman presented with a 2-month history of increasing pain in her right buttock, rectal tenesmus and uncontrolled micturition. Intradural extramedullary cystic lesion was found, and the characteristic MRI findings of a living cysticercus and a dying cysticercus were presented simultaneously.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!